REGULUS THERAPEUTICS INC.

(RGLS)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
2.070 USD    0.00%
06/29REGULUS THERAPEUTICS INC. : REVERSE SPLIT: 1 of 10
FA
06/28Wall Street Set to Open Higher
MT
06/28Top Premarket Decliners
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about REGULUS THERAPEUTICS INC.
06/29REGULUS THERAPEUTICS INC. : REVERSE SPLIT: 1 of 10
FA
06/28Wall Street Set to Open Higher
MT
06/28Top Premarket Decliners
MT
06/21Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for ..
PR
06/21Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for ..
CI
06/21Regulus Therapeutics Gets FDA Orphan Designation for RGLS8429
DJ
06/13Regulus Reports First Individual Dosed in Early-Stage Single-Ascending Dose Trial of RG..
MT
06/13Regulus Therapeutics Announces First Subject Dosed in Phase 1 Single-Ascending Dose (SA..
PR
06/13Regulus Therapeutics Inc. Announces First Subject Dosed in Phase 1 Single-Ascending Dos..
CI
06/02Regulus Appoints Amin Kamel, Ph.D., as Vice President, DMPK
PR
05/17Regulus Therapeutics to Present at the H.C. Wainwright Global Investment Conference
PR
05/12TRANSCRIPT : Regulus Therapeutics Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/12REGULUS : Q1 Earnings Snapshot
AQ
05/12Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31..
CI
05/12Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates
PR
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
MT
05/11SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance
MT
05/11SECTOR UPDATE : Health Care
MT
05/11Regulus Therapeutics' Shares Surge After FDA Accepts Investigational New Drug Applicati..
MT
05/11Regulus Therapeutics' Shares Climb After US FDA Accepts Investigational New Drug Applic..
MT
05/11Regulus Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Applica..
PR
05/11Regulus Therapeutics Inc. Announces FDA Acceptance of Investigational New Drug Applicat..
CI
05/05Regulus Therapeutics Announces Timing for First Quarter 2022 Financial Results Webcast ..
PR
03/24Regulus Therapeutics Initiates Studies for Potential Treatment of Lou Gehrig's Disease;..
MT
03/24Regulus Therapeutics Announces Initiation of Preclinical Studies in Amyotrophic Lateral..
PR
03/24Regulus Therapeutics Announces Initiation of Preclinical Studies in Amyotrophic Lateral..
CI
03/10TRANSCRIPT : Regulus Therapeutics Inc., Q4 2021 Earnings Call, Mar 10, 2022
CI
03/10REGULUS THERAPEUTICS : Reports Fourth Quarter and Year-End 2021 Financial Results and Rece..
PU
03/10REGULUS : Q4 Earnings Snapshot
AQ
03/10Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Rec..
PR
03/10Regulus Therapeutics Inc. Reports Earnings Results for the Fourth Quarter and Full Year..
CI
03/03Regulus Therapeutics Announces Timing for Fourth Quarter and Year-End 2021 Financial Re..
PR
02/24Regulus Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of La..
PR
02/24Regulus Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of La..
CI
02/10Regulus Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Confer..
PR
01/21Health Care Stocks Decline Pre-Bell Friday
MT
01/21Wedbush Adjusts Regulus Therapeutics' Price Target to $0.42 From $1 Following Private E..
MT
01/20Regulus Therapeutics Completes US FDA Meeting for Planned Kidney Disease Trial; Stock U..
MT
01/20Regulus Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA for RG..
PR
01/20Regulus Therapeutics Inc. Announces Successful Completion of Pre-Ind Meeting with FDA f..
CI
01/05Regulus Therapeutics Inc. Enters into Eleventh Amendment to its Loan and Security Agree..
CI
01/04Regulus Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference
PR
2021Regulus Appoints Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceuti..
PR
2021Regulus Therapeutics Announces Presentation at the First Annual Rare & Genetic Kidney D..
PR
2021Regulus Therapeutics Raises $34.6 Million in Common Stock Private Placement
MT
2021REGULUS THERAPEUTICS : SECURITIES PURCHASE AGREEMENT - Form 8-K
PU
2021Regulus Therapeutics Announces Closing of $34.6 Million Private Placement of Equity
PR
2021REGULUS THERAPEUTICS : Announces Private Placement of Equity - Form 8-K
PU
2021Regulus Therapeutics Launches $35 Million Private Placement
MT
2021Regulus Therapeutics Announces Private Placement of Equity
PR
2021Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates - ..
PU
2021TRANSCRIPT : Regulus Therapeutics Inc., Q3 2021 Earnings Call, Nov 10, 2021
CI
2021REGULUS : Q3 Earnings Snapshot
AQ
2021Regulus Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Month..
CI
2021Regulus Therapeutics Announces Timing for Third Quarter 2021 Financial Results Webcast ..
PR
2021AFTER HOURS WATCH LIST SCORECARD : Vst, stim, rgls
MT
2021Health Care Stocks Edging Higher Ahead of Wednesday Close
MT
2021Health Care Stocks Finding Increased Support This Afternoon
MT
2021Wall Street Wavers Pre-Bell as US Consumer Prices Rise More Than Expected, Fed Minutes ..
MT
2021Top Premarket Decliners
MT
2021MT NEWSWIRES AFTER HOURS WATCH LIST : Vst, stim, rgls
MT
2021TRANSCRIPT : Regulus Therapeutics Inc. - Special Call
CI
2021REGULUS THERAPEUTICS : Shifting Development Focus to Next-Generation Kidney Drug; Stock Pl..
MT
2021REGULUS THERAPEUTICS : Announces Strategic Prioritization of RGLS8429, its Next-Generation..
PR
2021Regulus Therapeutics Announces Strategic Prioritization of RGLS8429, its Next-Generatio..
CI
2021REGULUS THERAPEUTICS : to Present at the H.C. Wainwright 23rd Annual Global Investment Con..
PR
2021REGULUS THERAPEUTICS : Cantor Fitzgerald Reinstates Regulus Therapeutics at Overweight wit..
MT
2021TRANSCRIPT : Regulus Therapeutics Inc., Q2 2021 Earnings Call, Aug 10, 2021
CI
2021REGULUS : Q2 Earnings Snapshot
AQ
2021REGULUS THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Recent Updates (F..
PU
2021REGULUS THERAPEUTICS : Narrows Q2 Loss from Year Ago, Sees Enough Funds Till Q4 Next Year
MT
2021Regulus Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30..
CI
2021REGULUS THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Recent Updates
PR
2021REGULUS THERAPEUTICS : Announces Timing for Second Quarter 2021 Financial Results Webcast ..
PR
2021REGULUS THERAPEUTICS : Presents Additional Data from its Autosomal Dominant Polycystic Kid..
PR
1  2  3  4  5Next
Upcoming event on REGULUS THERAPEUTICS INC.